Date | Insider | Price | Amount |
---|---|---|---|
4-24-2024 Insider Buy |
Opaleye Management Inc. >10% Owner |
$10.23 CAGR » |
$204,640.10 20,000 shares |
4-19-2024 Insider Buy |
Opaleye Management Inc. >10% Owner |
$10.56 CAGR » |
$310,390.50 29,400 shares |
3-28-2024 Insider Buy |
Opaleye Management Inc. >10% Owner |
$12.82 CAGR » |
$641,000.00 50,000 shares |
3-22-2024 Insider Buy |
Mark L. Baum CHIEF EXECUTIVE OFFICER |
$11.59 CAGR » |
$104,310.00 9,000 shares |
3-20-2024 Insider Buy |
Opaleye Management Inc. >10% Owner |
$9.65 CAGR » |
$488,290.00 50,600 shares |
11-16-2023 Insider Buy |
Mark L. Baum Chief Executive Officer |
$8.11 CAGR » |
$60,825.00 7,500 shares |
9-20-2023 Insider Buy |
Opaleye Management Inc. >10% Owner |
$14.60 CAGR » |
$292,076.29 20,000 shares |
8-14-2023 Insider Buy |
Martin A. Makary Director |
$16.92 CAGR » |
$338,400.00 20,000 shares |
8-14-2023 Insider Buy |
Mark L. Baum Chief Executive Officer |
$17.05 CAGR » |
$98,890.00 5,800 shares |
12-14-2022 Insider Buy |
Opaleye Management Inc. >10% Owner |
$10.52 CAGR » |
$4,536,045.16 431,183 shares |
12-22-2022 Insider Buy |
R. Lawrence Van Horn Director |
$13.42 CAGR » |
$24,961.20 1,860 shares |
12-21-2022 Insider Buy |
Martin A. Makary Director |
$13.37 CAGR » |
$334,250.00 25,000 shares |
12-22-2022 Insider Buy |
Andrew R. Boll Chief Financial Officer |
$13.54 CAGR » |
$33,850.00 2,500 shares |
12-22-2022 Insider Buy |
Mark L. Baum Chief Executive Officer |
$13.39 CAGR » |
$334,750.00 25,000 shares |
9-28-2022 Insider Buy |
Opaleye Management Inc. >10% Owner |
$9.77 CAGR » |
$108,353.66 11,085 shares |
4-13-2022 Insider Buy |
Opaleye Management Inc. >10% Owner |
$6.75 CAGR » |
$279,502.30 41,389 shares |
8-19-2021 Insider Buy |
Opaleye Management Inc. >10% Owner |
$8.45 CAGR » |
$443,362.50 52,500 shares |
8-18-2021 Insider Buy |
Opaleye Management Inc. >10% Owner |
$8.62 CAGR » |
$624,697.15 72,500 shares |
7-21-2021 Insider Buy |
Opaleye Management Inc. >10% Owner |
$7.31 CAGR » |
$146,289.84 20,000 shares |
6-18-2021 Insider Buy |
Opaleye Management Inc. >10% Owner |
$8.34 CAGR » |
$622,389.01 74,584 shares |
12-22-2020 Insider Buy |
Opaleye Management Inc. >10% Owner |
$5.26 CAGR » |
$559,482.03 106,416 shares |
7-12-2020 Insider Buy |
Opaleye Management Inc. >10% Owner |
$4.97 CAGR » |
$560,132.67 112,700 shares |
7-9-2020 Insider Buy |
Opaleye Management Inc. >10% Owner |
$5.02 CAGR » |
$683,703.95 136,300 shares |
6-19-2020 Insider Buy |
Opaleye Management Inc. >10% Owner |
$5.58 CAGR » |
$195,401.50 35,000 shares |
6-4-2020 Insider Buy |
Opaleye Management Inc. >10% Owner |
$5.73 CAGR » |
$286,508.30 50,000 shares |
5-22-2020 Insider Buy |
Opaleye Management Inc. >10% Owner |
$4.85 CAGR » |
$125,665.89 25,900 shares |
Also See: Institutional Holders of HROW
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/25/2024 | |
End date: | 05/03/2024 | |
Start price/share: | $10.00 | |
End price/share: | $10.38 | |
Dividends collected/share: | $0.00 | |
Total return: | 3.80% | |
Annualized Gain: | 173.38% | |
Starting investment: | $10,000.00 | |
Ending investment: | $10,380.00 | |
Years: | 0.02 |
Harrow Health Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Harrow Health insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding HROW
Free HROW Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |